Immunome (IMNM) Other Operating Expenses (2023 - 2025)
Immunome's (IMNM) quarterly Other Operating Expenses came in at $10.0 million in Q4 2025, down 63.47% YoY from $27.4 million in Q4 2024, and down 63.47% on a QoQ basis from $27.4 million in Q4 2024.
Immunome (IMNM) Other Operating Expenses (2023 - 2025) Analysis & Trends
Immunome (IMNM) has 3 years of Other Operating Expenses data on file, last reported at $10.0 million in Q4 2025.
- Quarterly Other Operating Expenses fell 63.47% year-over-year to $10.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $10.0 million (down 75.24% YoY) and the FY2025 annual result came in at $10.0 million, down 93.44% from the prior year.
- Other Operating Expenses declined to $10.0 million in Q4 2025, from $27.4 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $112.0 million in Q1 2024 to a low of $6.3 million in Q2 2024.
- A 3-year average of $40.5 million and a median of $18.7 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses plunged 66.12% — and 2025, when it tumbled 63.47%.
- Tracing IMNM's Other Operating Expenses over 3 years: stood at $80.8 million in 2023, then sank by 66.12% to $27.4 million in 2024, then plunged by 63.47% to $10.0 million in 2025.
- The last three Other Operating Expenses figures came in at $10.0 million (Q4 2025), $27.4 million (Q4 2024), and $6.7 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 27.37 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 6.31 Mn |
| Mar 31, 2024 | 111.95 Mn |
| Dec 31, 2023 | 80.80 Mn |